Luke F. Chen, MBBS, MPH
Department / Division
Medicine /
Medicine-Infectious Diseases
Address
DUMC 102359
Durham, NC 27710
Appointment Telephone
919-684-4596
Office Telephone
919-684-4596
Fax Telephone
919-681-7494
- MBBS (Hons), University of Melbourne (Australia), 1999
- Internal Medicine, St. Vincent's Hospital (Australia), 2000-2004
- Infectious Diseases, The Alfred Hospital (Australia), 2004
- Infectious Diseases, Monash Medical Center (Australia), 2005
- Infectious Diseases (NCHECR HIV Clinical Research), The Alfred Hospital (Australia), 2006
- Infectious Diseases, Duke University Medical Center, 2007-2009
- Fellow, Royal Australasian College of Physicians (Australia), 2006
- Postgraduate Certificate in Clinical Trials, Monash University (Australia), 2007
- Certified in Infection Control, 2009
- MPH, Epidemiology, Johns Hopkins University, Bloomberg School of Public Health (Maryland), 2010
Clinical Interests
Multi-drug resistant organisms, drug-resistant gram-negative pathogens, health care epidemiology, HIV medicine, infection control and prevention, health care-associated infections including bloodstream and surgical-site infections
Research Interests
Multi-drug resistant organisms, drug-resistant gram-negative pathogens (e.g. ESBL, KPC, NDM-1), health care epidemiology, HIV medicine, respiratory viral infections, infection control and prevention, health care-associated infections including bloodstream and surgical-site infections
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- Cubist Pharmaceuticals, Inc.
- Medscape ( WebMD HLTH Corp.)
- Merck & Co. USA (not assoc'd with Merck KGaA)
Representative Publications
Ming DY, Chen LF, Miller BA, Anderson DJ. The impact of depth of infection and postdischarge surveillance on rate of surgical-site infections in a network of community hospitals. Infect Control Hosp Epidemiol. 2012 Mar;33(3):276-82.
(2012)
Abstract
Anderson DJ, Miller BA, Chen LF, Adcock LH, Cook E, Cromer AL, Louis S, Thacker PA, Sexton DJ. The network approach for prevention of healthcare-associated infections: long-term effect of participation in the duke infection control outreach network. Infect Control Hosp Epidemiol. 2011 Apr;32(4):315-22.
(2011)
Abstract
Chen LF, Dailey NJ, Rao AK, Fleischauer AT, Greenwald I, Deyde VM, Moore ZS, Anderson DJ, Duffy J, Gubareva LV, Sexton DJ, Fry AM, Srinivasan A, Wolfe CR. Cluster of Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Virus Infections on a Hospital Ward among Immunocompromised Patients--North Carolina, 2009. J Infect Dis. 2011 Mar;203(6):838-46.
(2011)
Abstract
Dimondi VP, Drew RH, Chen LF. Ceftaroline fosamil for treatment of communityacquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy. Expert Rev Anti Infect Ther. 2011 Aug;9(8):567-72.
(2011)
Abstract
Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals. Infect Control Hosp Epidemiol. 2011 Apr;32(4):387-90.
(2011)
Abstract
Chen LF, Anderson DJ, Kaye KS, Sexton DJ. Validating a 3-point prediction rule for surgical site infection after coronary artery bypass surgery. Infect Control Hosp Epidemiol. 2010 Jan;31(1):64-8.
(2010)
Abstract
Chen LF, Sexton DJ, Kaye KS, Anderson DJ. Patient-days: a better measure of incidence of occupational bloodborne exposures. Am J Infect Control. 2009 Sep;37(7):534-40.
(2009)
Abstract
Chen LF, Anderson DJ, Hartwig MG, Kaye KS, Sexton DJ. Surgical site infections after laparoscopic and open cholecystectomies in community hospitals . Infect Control Hosp Epidemiol. 2008 Jan;29(1):92-4; author reply 94-5.
(2008)
Abstract
